CYP 17.3% 30.5¢ cynata therapeutics limited

Ann: Positive 28-day Clinical Trial Data in Cohort B, page-48

  1. 1,141 Posts.
    lightbulb Created with Sketch. 218
    Nobel prize winning IPSCs to therapeutic MSCs..safety approved in human trial world first.
    Regen med market few years 130 bill plus.
    Cymerus equals consistant safe massively cost reduced commercial therapeutic stem cells.....available to all for royalty deal etc ..across almost entire regen market.
    No more batch to batch reg probs...
    Inject em in..get better for less..pay us!!

    $125 mill MC currently...?????

    If it aint over 500 mill by xmas im a bald ugly old git..well, im.that anyway..but u get my drift.

    Exit mc..over $800 mill..

    Ps people with spinal injuries are going to panama in wheelchairs and walking again..stem cells are real..
    Cymerus is even realer..nice english!!
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
0.045(17.3%)
Mkt cap ! $54.78M
Open High Low Value Volume
26.5¢ 31.5¢ 26.5¢ $35.96K 122.3K

Buyers (Bids)

No. Vol. Price($)
1 12995 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 10185 1
View Market Depth
Last trade - 15.59pm 18/06/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.